# Orasis Pharmaceuticals

> Ophthalmic pharmaceutical company (offices in the United States and Israel) developing and
> commercializing treatments for presbyopia. Maker of QLOSI (pilocarpine hydrochloride ophthalmic
> solution) 0.4%, an FDA-approved, preservative-free, single-use-vial prescription eye drop for
> age-related near-vision loss in adults.

Generated by API Evangelist on 2026-08-26 from apis.yml and live probes of the company's public
web surface. This file was GENERATED — Orasis Pharmaceuticals does not publish an llms.txt of its
own (https://orasis-pharma.com/llms.txt returned HTTP 404 on 2026-08-26).

## No API surface

Orasis Pharmaceuticals sells a regulated pharmaceutical product, not software. As of 2026-08-26 it
publishes **no public API, no developer portal, no SDK, no webhook surface and no machine-readable
API contract**. Every contract-discovery probe missed:

- `https://orasis-pharma.com/openapi.json` — 404 (HubSpot CMS HTML error page)
- `https://orasis-pharma.com/swagger.json` — 404
- `https://orasis-pharma.com/api-docs` — 404
- `https://orasis-pharma.com/graphql` — 404
- `https://orasis-pharma.com/.well-known/agent-card.json` — 404
- `https://orasis-pharma.com/.well-known/api-catalog` — 404
- the same paths on `qlosi.com` and `qlosiecp.com` — 404
- no first-party package on npm, PyPI or any other public registry
- no public repository (the `Orasis-Pharmaceuticals` GitHub organization exists but holds zero
  public repositories)

Do not attempt to call an Orasis API. There is nothing to call.

## Company

- [Orasis Pharmaceuticals](https://orasis-pharma.com/): Corporate site.
- [About](https://orasis-pharma.com/about): Company overview, offices, mission.
- [Leadership](https://orasis-pharma.com/leadership): Executive team.
- [Board](https://orasis-pharma.com/board): Board of directors.
- [Investors](https://orasis-pharma.com/investors): Life-sciences investors backing the company.
- [Contact](https://orasis-pharma.com/contact): Contact form and company addresses.

## Product

- [QLOSI](https://orasis-pharma.com/qlosi): Pilocarpine HCl ophthalmic solution 0.4% for presbyopia.
- [Presbyopia](https://orasis-pharma.com/presbyopia): Background on the condition.
- [Qlosi patient site](https://qlosi.com/): Patient-facing product information.
- [Qlosi for eye care professionals](https://qlosiecp.com/): Prescriber-facing product information.

## News

- [Press releases](https://orasis-pharma.com/press-releases): Dated company announcements. No RSS or
  Atom feed is published.
- [In the media](https://orasis-pharma.com/in-the-media): Third-party coverage.

## Policies

- [Terms of service](https://orasis-pharma.com/terms-of-service)
- [Privacy policy](https://orasis-pharma.com/privacy-policy)
- [Health data privacy policy](https://orasis-pharma.com/health-data-privacy-policy)

## About this file

This is a third-party profile maintained by API Evangelist (https://apievangelist.com). It is not
authored by, affiliated with, or endorsed by Orasis Pharmaceuticals. Corrections and removal
requests: info@apievangelist.com.